Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: TAXUS Liberté™-SR

First Posted Date: 2006-09-04

Last Posted Date: 2012-02-02

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 247

Registration Number: NCT00371423

Locations: 🇺🇸
University of Arkansas for Medical Sciences/Central Arkansas Veterans Healthcare Systems, Little Rock, Arkansas, United States
🇺🇸
Mercy General Hospital, Sacramento, California, United States
🇺🇸
University of California San Diego Medical Center, San Diego, California, United States

and more 22 locations

Spinal Cord Stimulation for Chronic and Intractable Back Pain

Not Applicable

Terminated

Conditions: Back Pain

Interventions: Device: Precision Spinal Cord Stimulation System

First Posted Date: 2006-09-01

Last Posted Date: 2020-12-17

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 15

Registration Number: NCT00370695

Locations: 🇺🇸
Huntley Pain Specialists, San Diego, California, United States

Comparison of Intraspinal Nerve Root Stimulation With Dorsal Column Stimulation

Phase 4

Terminated

Conditions: Back Pain

First Posted Date: 2006-09-01

Last Posted Date: 2008-09-05

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 4

Registration Number: NCT00370773

Locations: 🇺🇸
Comprehensive Pain & Rehabilitation, Daphne, Alabama, United States

Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries

Phase 3

Completed

Conditions: Arterial Occlusive Disease
Intermittent Claudication
Atherosclerotic Disease
Thrombosis

First Posted Date: 2006-07-14

Last Posted Date: 2008-09-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 150

Registration Number: NCT00352222

Locations: 🇧🇪
Limburgs Vaatcentrum Ziekenhuis Oost-Limburg, Genk, Belgium
🇧🇪
Sint Trudo Hospital, Sint Truiden, Belgium
🇨🇦
CHUM- Notre Dame Hospital, Montreal, Quebec, Canada

and more 7 locations

TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients

Phase 4

Completed

Conditions: Heart Failure, Congestive

Interventions: Device: Dual (atrial and ventricular) implantable defibrillator

First Posted Date: 2006-06-28

Last Posted Date: 2017-03-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 420

Registration Number: NCT00345592

Locations: 🇮🇹
Istituto di Clinica Medica I° e Cardiologia A.O.C., Careggi, Italy
🇮🇹
Azienda Ospedale S. Anna, San Fermo della Battaglia (CO), Italy

TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?

Not Applicable

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2006-06-27

Last Posted Date: 2008-10-08

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 2500

Registration Number: NCT00344630

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States

RAPID-RF: Remote Active Monitoring in Patients With Heart Failure

Completed

Conditions: Heart Failure

First Posted Date: 2006-06-07

Last Posted Date: 2014-02-24

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 891

Registration Number: NCT00334451

Locations: 🇺🇸
Long Island Jewish Medical Center, New Hyde Park, New York, United States

Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)

Not Applicable

Completed

Conditions: Carotid Artery Diseases
Stroke
Cerebral Arteriosclerosis

Interventions: Device: WALLSTENT® Endoprosthesis™

First Posted Date: 2006-04-20

Last Posted Date: 2014-08-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 747

Registration Number: NCT00316108

Locations: 🇺🇸
Bapatist Medical Center, Birmingham, Alabama, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Arizona Heart Institute, Phoenix, Arizona, United States

and more 47 locations

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions

Phase 2

Completed

Conditions: Coronary Stenosis

Interventions: Device: TAXUS Paclitaxel-Eluting Coronary Stent, Slow-Formulation
Device: Express2

First Posted Date: 2006-03-13

Last Posted Date: 2010-08-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1108

Registration Number: NCT00301522

Locations: 🇺🇸
Baptist Medical Center Princeton, Birmingham, Alabama, United States
🇺🇸
Cardiovascular Associates PC/Baptist Medical Center Montclair, Birmingham, Alabama, United States
🇺🇸
UAB Interventional Cardiology, Birmingham, Alabama, United States

and more 69 locations

A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent

Phase 2

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2006-03-06

Last Posted Date: 2017-03-03

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 532

Registration Number: NCT00299026

Locations: 🇮🇹
San Raffaele del Monte Tabor, Milano, Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy